ABSTRACT
Copper T-380 A was inserted to 300 women seeking contraception. 100 were given a prostagl and in synthetase inhibitor [mefenamic acid], the second 100 were given an antifibrinolytic [tranexamic acid] after IUD insertion and with the subsequent two cycles. The third 100 were given no treatment post-IUD insertion. The incidence of pain, bleeding and IUD removals on account of pain and bleeding was significantly less in women given mefenamic or tranexamic acid. The incidence of pain was less in women given an antiprostagl and in compared to those who were given an antifibriolytic. Therefore, the prophylactic use of a prostagl and in synthetase inhibitor was recommended in the regimen described in women choosing the IUJD for contraception
Subject(s)
Humans , Female , Intrauterine Devices/adverse effectsABSTRACT
A retorspective study of ectopic pregnancies in a period of 5 years was performed. The incidence was 1: 350 live births. The clinical presentation. methods of diagnosis and surgical management were discussed
Subject(s)
Retrospective StudiesABSTRACT
Sixty parturients, for whom planned vaginal delivery following a prior C.S., were studied. 32 had epidural analgesia for labor pain relief while 28 had nitrous oxide analgesia. Monitoring of maternal vital signs, fetal heart sounds and progress of labor were done. All patients were safely delivered. 54 had successful vaginal delivery and 6 patients had repeat C.S. There was no case of uterine rupture. All babies were above Apgar 7 at 5 minutes. Mothers were more satisfied with epidural analgesia than with nitrous oxide inhalation. While pain is unreliable in diagnosing uterine rupture, epidural analgesia allowed manual examination of the previous scar easily the latter is a more reliable sign in diagnosis. We conclude that, provided adequate feto-maternal monitoring is done epidural analgesia is both safe and advantageous for trial vaginal delivery following prior C.S. and that ruptured uterus is a rare occurrence in this setting